Cargando…
Identification of Potential Therapeutic Drugs for Huntington's Disease using Caenorhabditis elegans
BACKGROUND: The prolonged time course of Huntington's disease (HD) neurodegeneration increases both the time and cost of testing potential therapeutic compounds in mammalian models. An alternative is to initially assess the efficacy of compounds in invertebrate models, reducing time of testing...
Autores principales: | Voisine, Cindy, Varma, Hemant, Walker, Nicola, Bates, Emily A., Stockwell, Brent R., Hart, Anne C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876812/ https://www.ncbi.nlm.nih.gov/pubmed/17551584 http://dx.doi.org/10.1371/journal.pone.0000504 |
Ejemplares similares
-
The nematode Caenorhabditis elegans displays a chemotaxis behavior to tuberculosis-specific odorants
por: Neto, Mário F., et al.
Publicado: (2016) -
Identification of Pseudomonas aeruginosa Phenazines that Kill Caenorhabditis elegans
por: Cezairliyan, Brent, et al.
Publicado: (2013) -
Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification
por: Kobet, Robert A., et al.
Publicado: (2014) -
Genetic Identification of Separase Regulators in Caenorhabditis elegans
por: Melesse, Michael, et al.
Publicado: (2017) -
Caenorhabditis Elegans
Publicado: (2000)